Baxter International | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Abbott USD 5.92B 114M 2025-03
AtriCure USD 92.62M 5.83M 2024-12
Avanos Medical USD 98M 5.1M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Boston Scientific USD 3.2B 97M 2025-03
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Fresenius EUR 1.42B 52M 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
ICU Medical USD 227.26M 22.41M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Laboratory Of America USD 896.3M 8.1M 2024-12
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.02M 963K 2025-03
Quest Diagnostics USD 869M 11M 2025-03
Smith & Nephew USD 2.07B 98M 2024-12
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Terumo JPY 145.12B 5.66B 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Baxter International سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Apr 2025.